Advertisement
Advertisement

HIV Care Today


More Evidence That Early HIV Treatment -- REALLY Early -- Is Beneficial
By Paul E. Sax, M.D.
January 16, 2013

Management of recently acquired HIV infection -- especially acute HIV, pre-seroconversion -- has long been controversial, with the risks and benefits of treatment versus observation debated now for nearly two decades.

(Yes, it's been that long since the publication of this controlled trial of zidovudine monotherapy. Amazing.)

Read more …


How Can "JAK Inhibitors" Help Salvage Patients and the Search for an HIV Cure?
By Nelson Vergel, B.S.Ch.E., M.B.A.
January 15, 2013

As part of my work as an HIV cure and salvage treatment activist, I am constantly searching for treatment options that could serve two purposes: help patients with multidrug resistance, and at the same time be used as an approach to cure HIV. Since my nonprofit, Program for Wellness Restoration (PoWeR), has a very small budget for me to attend conferences, I rely on the summaries that Jules Levin and his group at National AIDS Treatment Advocacy Project (NATAP) publish after he attends conferences. I am glad Jules can serve as eyes and ears for those of us who are unable to attend so many important scientific meetings.

Read more …


HIV Exceptionalism Is Alive and Well -- and That's Too Bad
By Paul E. Sax, M.D.
January 9, 2013

Email exchange with a colleague who works at one of our community health clinics:

Guy: Hi Paul, your patient 17432862 [that's a made-up medical record number] came to our walk-in clinic with a rash on her hand. OK that I gave her a week of topical steroids? I know how inhaled steroids interact with some meds -- wasn't sure about the creams.

Me: Could be, good thought. Regardless, a short course should be fine. Tell me, who is the patient? What meds is she on?

Guy: I didn't want to put her name or meds in the email, what with her disease state, HIPAA, etc.

Read more …


What's a Fulyzaq? I Thought You'd Never Ask
By Paul E. Sax, M.D.
January 3, 2013

As Physician's First Watch noted, we sure know what the folks at the FDA were doing this holiday season -- and most emphatically they weren't visiting Aunt Selma in Boca Raton.

Read more …


HIV Incidence: The Latest Numbers
By Paul E. Sax, M.D.
January 1, 2013

The CDC has recently issued the latest report on HIV incidence (i.e., new infections) in the United States, and as always it's fascinating to review the numbers.

Read more …


The U.S. Preventive Services Task Force Recommends HIV Screening -- And Why Is This News?
By Paul E. Sax, M.D.
November 22, 2012

A flurry of coverage recently appeared about the U.S. Preventive Services Task Force's recommendation for one-time HIV screening for all Americans, ages 15-64.

Some might wonder why this is news -- um, hasn't this been recommended now for years? -- and I think I've figured it out.

Read more …


The 800-mg Darunavir Tablet Arrives, and Scoring the Top Protease Inhibitors
By Paul E. Sax, M.D.
November 18, 2012

The FDA has approved an 800-mg tablet of darunavir for treatment naive patients. This single tablet will obviously replace the two darunavir 400-mg tablets in first-line therapy. (Yes, my math is that good.) Darunavir will still require 100-mg ritonavir boosting plus two NRTIs to make a complete regimen.

Read more …


Vitamins and the Department of Bad Timing
By Paul E. Sax, M.D.
November 7, 2012

Now that the election is over, we can get back to something that really matters -- namely vitamins, and specifically whether they really help people.

Read more …


Antiretroviral Rounds: Resistance on Two Fronts
By Paul E. Sax, M.D.
November 2, 2012

Got this challenging curbside consult from a colleague, and it has an interesting wrinkle.

Read more …


Dolutegravir and the 88 Percent Rule
By Paul E. Sax, M.D.
October 28, 2012

In the latest treatment-naive trials of elvitegravir and dolutegravir, there's a striking consistency in the results of the "test" regimen. Here are the studies, with the percentage of responders by treatment arm ...

Read more …

 < Prev  |  1  |  …  |  3  |  4  |  5  |  6  |  7  |  …  |  14  |  Next > 

Get email notifications every time HIV Care Today is updated.



This article was provided by TheBodyPRO.com.
 

Advertisement